"The volume of clinical and biomedical research is growing exponentially, making it nearly impossible to analyze the efficacy, safety, and cost-effectiveness of every medical device manually," said ...
Symplr, backed by Clearlake Capital Group and SkyKnight Capital, has agree to acquire HealthcareSource HR from Francisco Partners. TripleTree advised HealthcareSource, while William Blair advised ...
Veritas Capital’s pending sale of API Healthcare to Clearlake Capital Group’s Symplr is valued between the high $200 million range and $300 million, according to two people with knowledge of the ...
AI-powered solution leverages data in the symplr Operations Platform to evaluate new medical devices or technologies HOUSTON, March 3, 2025 /PRNewswire/ -- symplr ®, a leading provider of enterprise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results